Lee Junghye, Yoo Youngeun, Park Sanghui, Cho Min-Sun, Sung Sun Hee, Ro Jae Y
Department of Pathology, Ewha Womans University College of Medicine, Seoul, Korea.
Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Weill Medical College of Cornell University, Houston, TX, USA.
J Pathol Transl Med. 2020 Mar;54(2):146-153. doi: 10.4132/jptm.2019.11.12. Epub 2020 Feb 10.
Distinguishing prostatic stromal invasion (PSI) by urothelial carcinoma (UC) from in situ UC involving prostatic ducts or acini with no stromal invasion (in situ involvement) may be challenging on hematoxylin and eosin stained sections. However, the distinction between them is important because cases with PSI show worse prognosis. This study was performed to assess the utility of double cocktail immunostains with high molecular weight cytokeratin (HMWCK) and GATA-3 to discriminate PSI by UC from in situ UC involvement of prostatic ducts or acini in the prostate.
Among 117 radical cystoprostatectomy specimens for bladder UCs, 25 cases showed secondary involvement of bladder UC in prostatic ducts/acini only or associated stromal invasion and of these 25 cases, seven cases revealed equivocal PSI. In these seven cases with equivocal PSI, HMWCK, and GATA-3 double immunohistochemical stains were performed to identify whether this cocktail stain is useful to identify the stromal invasion.
In all cases, basal cells of prostate glands showed strong cytoplasmic staining for HMWCK and UC cells showed strong nuclear staining for GATA-3. In cases with stromal invasion of UC, GATA-3-positive tumor cells in the prostatic stroma without surrounding HMWCK-positive basal cells were highlighted and easily recognized. Among seven equivocal cases, two cases showed PSI and five in situ UC in the prostate. In two cases, the original diagnoses were revised.
Our study suggested that HMWCK and GATA-3 double stains could be utilized as an adjunct method in the distinction between PSI by UC from in situ UC involving prostatic ducts or acini.
在苏木精和伊红染色切片上,区分尿路上皮癌(UC)的前列腺间质浸润(PSI)与累及前列腺导管或腺泡但无间质浸润的原位UC(原位累及)可能具有挑战性。然而,区分它们很重要,因为伴有PSI的病例预后较差。本研究旨在评估高分子量细胞角蛋白(HMWCK)和GATA-3双重鸡尾酒免疫染色在鉴别前列腺中UC的PSI与原位累及前列腺导管或腺泡的原位UC方面的效用。
在117例膀胱UC根治性膀胱前列腺切除术标本中,25例仅显示膀胱UC对前列腺导管/腺泡的继发性累及或伴有间质浸润,在这25例中,7例显示PSI不明确。在这7例PSI不明确的病例中,进行了HMWCK和GATA-3双重免疫组化染色,以确定这种鸡尾酒染色是否有助于识别间质浸润。
在所有病例中,前列腺腺泡的基底细胞对HMWCK呈强细胞质染色,UC细胞对GATA-3呈强核染色。在伴有UC间质浸润的病例中,前列腺间质中GATA-3阳性肿瘤细胞周围无HMWCK阳性基底细胞,易于识别。在7例不明确的病例中,2例显示前列腺中有PSI,5例为原位UC。2例病例的原诊断被修正。
我们的研究表明,HMWCK和GATA-3双重染色可作为一种辅助方法,用于区分前列腺中UC的PSI与原位累及前列腺导管或腺泡的原位UC。